BioCentriq (Series A)
Funding Details
Awarder
Inbox
Date Award
January 3, 2024
Vertical
Cell Therapy
Funding Amount
$29,200,000
Company Info
Market
Clinical Trials
Location
Newark, NJ, USA
Company Description

BioCentriq is a global leader in cell therapy Contract Development and Manufacturing, with a proven track record successfully transferring, developing, and manufacturing GMP drug product for use in clinical trials. With state-of-the-art facilities, advanced technologies, and a team of experienced professionals, BioCentriq is dedicated to advancing innovation in cell therapy and supporting its partners to bring life-changing treatments to patients worldwide.

Links